Park Avenue Compounding: Drug Recall
Recall #D-0178-2026 · 09/23/2025
Class II: Risk
Recall Details
- Recall Number
- D-0178-2026
- Classification
- Class II
- Product Type
- Drug
- Recalling Firm
- Park Avenue Compounding
- Status
- Ongoing
- Date Initiated
- 09/23/2025
- Location
- Saint Louis, MO, United States
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 189 bags
Reason for Recall
CGMP Deviations: Revised interpretation of Acceptable Quality Level (AQL) results.
Product Description
Fentanyl citrate, 2 mcg / ml / Ropivacaine, 0.2% in NS 150 mL, CII, 150 mL bag, Rx Only, Park Avenue Compounding, 3662 Park Ave, Saint Louis, MO, 63110, NDC 83863-4272-1.
Distribution Pattern
Distributed in Missouri
Other Recalls by Park Avenue Compounding
- Class II: Risk 09/17/2025
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.